NDC 61010-2017-00 - Walgreens
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 61010-2017
- Requested NDC
- 61010-2017-00
- Package NDCs from labels
- 61010-2017-0, 61010-2017-1, 61010-2017-00
- Manufacturer
- Walgreen Co.
- Effective date
- 2026-07-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Walgreens All-Purpose First Aid Kit 150 pieces | Walgreen Co. | 2026-07-09 | HUMAN OTC DRUG LABEL |
| Care Science - ASO LLC | ASO LLC | 2026-07-08 | HUMAN OTC DRUG LABEL |
| Care Science Essential First Aid - ASO LLC | ASO LLC | 2024-08-29 | HUMAN OTC DRUG LABEL |
| All-Health Wound Care Kit - ASO LLC | ASO LLC | 2024-08-20 | HUMAN OTC DRUG LABEL |
| Antiseptic - Safetec of America, Inc. | Safetec of America, Inc | Safetec of America, Inc. | Safetec of America, Inc | 2024-02-05 | HUMAN OTC DRUG LABEL |
| Care Science OSHA First Aid - ASO LLC | ASO LLC | 2024-02-05 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61010-2017-0 | Antiseptic | 0.0019 L in 1 PACKET | CLOTH | 0.0019 | 3 | |
| 61010-2017-1 | Antiseptic | 100 in 1 BOX | CLOTH | 100 | 3 | |
| 61010-2017-1 | Antiseptic | 0.0019 L in 1 PACKET | CLOTH | 0.0019 | 3 | |
| 61010-2017-0 | All-Health Wound Care Kit | 0.0019 L in 1 PACKET | CLOTH | 0.019 L | 665 mL in 1L | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61010-2017 | ANTISEPTIC (ALCOHOL) CLOTH [SAFETEC OF AMERICA, INC.] | 3 | Current NDC, Legacy NDC, 3 package rows | 20240214_aeecceb7-0753-4908-b1a2-d7e18ba350ec.zip |
| 61010-2017 | CARE SCIENCE ESSENTIAL FIRST AID (ETHYL ALCOHOL, ISOPROPYL ALCOHOL, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN-B SULFATE) KIT [ASO LLC] | 3 | Current NDC, Legacy NDC | 20240830_4e53fc6b-4774-4224-8759-eadd150ff959.zip |
| 61010-2017 | CARE SCIENCE OSHA FIRST AID (ETHYL ALCOHOL, ISOPROPYL ALCOHOL, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN-B SULFATE, DIPHENHYDRAMINE HYDROCHLORIDE, HYDROCORTISONE, IBUPROFEN, ACETAMINOPHEN, WATER) KIT [ASO LLC] | 2 | Current NDC, Legacy NDC | 20241107_1cbace4d-fd0a-41d1-aa71-907d43620bf8.zip |
| 61010-2017 | ALL-HEALTH WOUND CARE KIT (ETHYL ALCOHOL) KIT [ASO LLC] | 1 | Current NDC, Legacy NDC | 20240823_939ff14f-bdfe-408a-bc4b-71da3bae194d.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HERA SILKYSTAY FOUNDATION 17N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb363fe-c2b2-9381-e063-6294a90ad038 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 17W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb39387-7f6b-ce78-e063-6394a90a15ae | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 21C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb3c3ad-8a77-0655-e063-6394a90ae9e0 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 21N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb3ddb5-4e2b-17d4-e063-6394a90aaa55 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 22N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb415b3-b1ba-42b8-e063-6394a90a90d7 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 21W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb42062-f298-5186-e063-6294a90ab043 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 23C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb44e1b-b24b-6c83-e063-6394a90a4b52 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 23W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb468db-3c38-922d-e063-6294a90adef8 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 24N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb4b8ca-eced-b7ff-e063-6394a90aaefe | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 24O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb4f87a-b4dc-1aa5-e063-6294a90a2ec4 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 25W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb50784-444e-3bf3-e063-6294a90aa618 | 2026-10-25 | Warnings | 15FIX9V2JP |
| Non Proprietary Name | PERIOD PATCH | Nanjing 3H Medical Products Co., Ltd. | 5eb6ada9-5217-706b-e063-6394a90aeccc | 2026-10-25 | Warnings | M017 |
| Mucinex Fast-Max Kickstart Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | fda745ca-b486-47ca-e053-6394a90a87c3 | 2026-10-24 | Warnings | M012 362O9ITL9D |
| Mucinex Fast-Max Kickstart Severe Congestion and Cough and Mucinex Fast-Max Nighttime Cold and Flu | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, ACETAMINOPHEN,TRIPROLIDINE HYDROCHLORIDE | Reckitt Benckiser LLC | 34fd2458-9acd-cdf7-e063-6394a90a3d0a | 2026-10-24 | Warnings | M012 |
| Excedrin Migraine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Select Consumer Group | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2026-10-24 | Warnings | 362O9ITL9D |
| Bayer Genuine Aspirin | ASPIRIN | Select Consumer Group | 3ca776c2-47ed-5107-e063-6394a90ac5df | 2026-10-24 | Warnings | M013 |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | Select Consumer Group | 3caa0a47-de83-90d2-e063-6394a90a3436 | 2026-10-24 | Warnings | M013 362O9ITL9D |
| DAYTIME NIGHTTIME COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Amazon.com Services LLC | e1b2d448-f84f-49ec-821c-ad03c4c6a59a | 2026-10-23 | Warnings | M012 |
| Aspi-Cor | ASPIRIN | L.N.K. International, Inc. | 9f919a48-ffd8-49fa-b6fd-ec71cc12e64b | 2026-10-23 | Warnings | M013 |
| Skyrizi | RISANKIZUMAB-RZAA | AbbVie Inc. | 7148c8eb-b39e-e20a-6494-a6df82392858 | 2026-10-23 | Warnings, Adverse reactions | 797544 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.